Doctor profile · Federal record
Dr. Jeffrey Medland, DO
Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Endocrinology, Diabetes & Metabolism Physician · Anchorage, AK
- NPI 1780733105
- Accepts Medicare
- MIPS 82.1 / 100 · 2023
- 38 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2841 Debarr RD, Suite 43
Anchorage, AK 995082958
(907) 274-7847
fax (907) 274-7845
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- June 10, 2014
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Alaska #7131 · Illinois #036084627
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1780733105. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
134
Distinct HCPCS
4
Medicare allowed
$17,143
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 67 | 42 | $152 | |
10005 |
Fine needle aspiration biopsy using ultrasound guidance, first growth | 28 | 25 | $98 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 25 | 17 | $131 | |
10006 |
Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 14 | 12 | $67 |
In context: peer comparison
Among 4 peers in Anchorage Endocrinology, Diabetes & Metabolism Physician, average services per provider: 101. This provider delivers 1.3× the peer median.Open Payments
Industry payments received
All-time total
$1,880
Transactions
44
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $458.09 | |
| Amgen INC. | 4 | $319.26 | |
| AstraZeneca Pharmaceuticals Lp | 3 | $199.42 | |
| Novo Nordisk INC | 2 | $148.53 | |
| Sanofi-Aventis U.S. LLC | 3 | $134.76 | |
| Abbvie INC. | 4 | $132.46 | |
| Otsuka America Pharmaceutical, INC. | 1 | $117.43 | |
| Medtronic, INC. | 2 | $87.28 | |
| Regeneron Healthcare Solutions, INC. | 1 | $83.14 | |
| Xeris Pharmaceuticals, INC. | 2 | $32.06 | |
| Alexion Pharmaceuticals, INC. | 1 | $27.92 | |
| Calliditas Therapeutics US INC. | 1 | $25.93 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 1 | $24.44 | |
| Tandem Diabetes Care, INC. | 1 | $24.27 | |
| Recordati_Rare_Diseases_INC. | 1 | $23.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
121
Patients
28
Total drug cost
$3,526
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Synthroid (Levothyroxine Sodium) | Brand | 53 | 17 | $2,223 |
| Rosuvastatin Calcium | Generic | 29 | 0 | $437 |
| Levothyroxine Sodium | Generic | 28 | 11 | $382 |
| Hydrocortisone | Generic | 11 | 0 | $484 |
Hospital affiliations
Frequently asked questions
What is Dr. Jeffrey Medland's medical specialty?
Dr. Jeffrey Medland practices Endocrinology, Diabetes & Metabolism Physician in Anchorage, AK.
Where does Dr. Jeffrey Medland practice?
Dr. Jeffrey Medland practices at 2841 Debarr RD, Anchorage, AK 995082958. Office phone: 9072747847.
What is Dr. Jeffrey Medland's NPI?
Dr. Jeffrey Medland's National Provider Identifier (NPI) is 1780733105, issued by NPPES.
Does Dr. Jeffrey Medland accept Medicare assignment?
Yes. Dr. Jeffrey Medland accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Medland commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Fine needle aspiration biopsy using ultrasound guidance, first growth (HCPCS 10005); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.